Friday, October 06, 2017 6:40:04 PM
1. WDDD owns 5,936,115 shares, NOT 6,596,667 (MRMD 10-K), as I have been falsely accused.
2. Institutional investors almost never invest in true penny stocks. And it's funny that someone mentioned institutional investors having positions in micro-cap stocks. Micro-cap stocks are somewhere around $150M market cap, maybe as low as $75M. WDDD has a market cap of less than $10M. Institutional investors do NOT invest in companies like WDDD. Absolute lie.
3. WDDD is currently at $.0386, not sub-$0.02 as some have been stating for months this is heading to, and is up 25% in the last 3 months.
4. The noteholders, whose notes are in default, are shareholders and have it in their best financial interest, as shareholders, to avoid dilution of their own shares at any cost. A company doesn't have to hold your hand through its every future decision in a financial statement. Additionally, rolling over a note is a NOTEHOLDER decision, not a COMPANY decision. That's why it wouldn't be in a financial statement because it's not a decision the company makes.
5. The current market value of WDDD's patents are $11,563,000 without any doubt. Don't let anyone tell you that accrued expenses aren't a part of a company's valuation as a liability and don't let anyone tell you WDDD owns 6.5M shares of MRMD. Do the sum of parts valuation yourself and it's quite easy to calculate $11,563,000. Ask your own finance colleagues or finance professors and the answer to this debate is extremely simple. They would laugh in your face if you were trying to calculate an asset value and subtracted liabilities from equity to arrive at it.
6. Considering that patent infringers win 33% of their court cases historically, the market actually thinks that if there is a win in court, the market believes the patents will return $34,690,000 ($34,690,000*33% = $11,563,000).
Recent WDDD News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 01:27:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:16:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:47:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:21 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM